BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1975 related articles for article (PubMed ID: 18990174)

  • 1. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.
    Canter D; Guzzo T; Resnick M; Magerfleisch L; Sonnad S; Bergey M; Tomazewski J; Vaughn D; Van Arsdalen K; Malkowicz B
    BJU Int; 2008 Sep; 102(8):952-7. PubMed ID: 18485042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
    J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens.
    Resnick MJ; Bergey M; Magerfleisch L; Tomaszewski JE; Malkowicz SB; Guzzo TJ
    BJU Int; 2011 Jan; 107(1):46-52. PubMed ID: 20880163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
    Bolenz C; Herrmann E; Bastian PJ; Michel MS; Wülfing C; Tiemann A; Buchner A; Stief CG; Fritsche HM; Burger M; Wieland WF; Höfner T; Haferkamp A; Hohenfellner M; Müller SC; Ströbel P; Trojan L
    BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
    Shariat SF; Svatek RS; Tilki D; Skinner E; Karakiewicz PI; Capitanio U; Bastian PJ; Volkmer BG; Kassouf W; Novara G; Fritsche HM; Izawa JI; Ficarra V; Lerner SP; Sagalowsky AI; Schoenberg MP; Kamat AM; Dinney CP; Lotan Y; Marberger MJ; Fradet Y
    BJU Int; 2010 May; 105(10):1402-12. PubMed ID: 20132195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
    Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR
    BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
    BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
    Palmieri F; Brunocilla E; Bertaccini A; Guidi M; Pernetti R; Morselli-Labate AM; Martorana G
    Anticancer Res; 2010 Jul; 30(7):2973-6. PubMed ID: 20683041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
    Cai T; Tiscione D; Verze P; Pomara G; Racioppi M; Nesi G; Barbareschi M; Brausi M; Gacci M; Luciani LG; Liguori G; Gontero P; Campodonico F; Simonato A; Boddi V; Di Stasi SM; Colombo R; Serretta V; Carmignani G; Malossini G; Altieri V; Carini M; Terrone C; Bassi P; Montorsi F; Ficarra V; Selli C; Mirone V; Bartoletti R
    Urology; 2014 Nov; 84(5):1141-6. PubMed ID: 25239253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 99.